The functional role of long non-coding RNA in human carcinomas

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Gibb, Ewan A ^a   Brown, Carolyn J ^a,b   Lam, Wan L ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

UNTRANSLATED RNA; MICRORNA;

CANCER GENETICS; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA; GENE EXPRESSION; HUMAN; REVIEW; RNA ANALYSIS; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 79953888460     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-38     Document Type: Review

References (277)

1. Stein LD. Human genome: end of the beginning. Nature 2004, 431(7011):915-916. 10.1038/431915a, 15496902.
2. Ponting CP, Belgard TG. Transcribed dark matter: meaning or myth?. Hum Mol Genet 2010, 19(R2):R162-168. 10.1093/hmg/ddq362, 20798109.
3. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447(7146):799-816. 10.1038/nature05874, 2212820, 17571346.
4. Costa FF. Non-coding RNAs: Meet thy masters. Bioessays 2010, 32(7):599-608. 10.1002/bies.200900112, 20544733.
5. Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 2007, 8(6):413-423. 10.1038/nrg2083, 17486121.
6. Frith MC, Pheasant M, Mattick JS. The amazing complexity of the human transcriptome. Eur J Hum Genet 2005, 13(8):894-897. 10.1038/sj.ejhg.5201459, 15970949.
7. Khachane AN, Harrison PM. Mining mammalian transcript data for functional long non-coding RNAs. PLoS One 2010, 5(4):e10316. 10.1371/journal.pone.0010316, 2859052, 20428234.
8. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458(7235):223-227. 10.1038/nature07672, 2754849, 19182780.
9. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006, 15(1):R17-29. 10.1093/hmg/ddl046, 16651366.
10. Washietl S, Hofacker IL, Lukasser M, Huttenhofer A, Stadler PF. Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome. Nat Biotechnol 2005, 23(11):1383-1390. 10.1038/nbt1144, 16273071.
11. Wang J, Zhang J, Zheng H, Li J, Liu D, Li H, Samudrala R, Yu J, Wong GK. Mouse transcriptome: neutral evolution of 'non-coding' complementary DNAs. Nature 2004, 431(7010):1. p following 757; discussion following 757.
12. Struhl K. Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat Struct Mol Biol 2007, 14(2):103-105. 10.1038/nsmb0207-103, 17277804.
13. Ebisuya M, Yamamoto T, Nakajima M, Nishida E. Ripples from neighbouring transcription. Nat Cell Biol 2008, 10(9):1106-1113. 10.1038/ncb1771, 19160492.
14. van Bakel H, Nislow C, Blencowe BJ, Hughes TR. Most "dark matter" transcripts are associated with known genes. PLoS Biol 2010, 8(5):e1000371. 10.1371/journal.pbio.1000371, 2872640, 20502517.
15. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009, 23(13):1494-1504. 10.1101/gad.1800909, 19571179.
16. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641. 10.1016/j.cell.2009.02.006, 19239885.
17. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009, 10(3):155-159. 10.1038/nrg2521, 19188922.
18. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323. 10.1016/j.cell.2007.05.022, 2084369, 17604720.
19. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010, 42(12):1113-1117. 10.1038/ng.710, 3040650, 21057500.
20. Castle JC, Armour CD, Lower M, Haynor D, Biery M, Bouzek H, Chen R, Jackson S, Johnson JM, Rohl CA, et al. Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One 2010, 5(7):e11779. 10.1371/journal.pone.0011779, 2909899, 20668672.
21. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 2008, 105(2):716-721. 10.1073/pnas.0706729105, 2206602, 18184812.
22. Wu SC, Kallin EM, Zhang Y. Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res 2010, 20(10):1109-1116. 10.1038/cr.2010.114, 2949548, 20680032.
23. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010, 220(2):126-139. 10.1002/path.2638, 19882673.
24. Maruyama R, Shipitsin M, Choudhury S, Wu Z, Protopopov A, Yao J, Lo PK, Bessarabova M, Ishkin A, Nikolsky Y, et al. Breast Cancer Special Feature: Altered antisense-to-sense transcript ratios in breast cancer. Proc Natl Acad Sci USA 2010,
25. Silva JM, Perez DS, Pritchett JR, Halling ML, Tang H, Smith DI. Identification of long stress-induced non-coding transcripts that have altered expression in cancer. Genomics 2010, 95(6):355-362. 10.1016/j.ygeno.2010.02.009, 20214974.
26. Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS, Smith DI. Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet 2008, 17(5):642-655. 10.1093/hmg/ddm336, 18006640.
27. Guffanti A, Iacono M, Pelucchi P, Kim N, Solda G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009, 10:163. 10.1186/1471-2164-10-163, 2678161, 19379481.
28. Brosnan CA, Voinnet O. The long and the short of noncoding RNAs. Curr Opin Cell Biol 2009, 21(3):416-425. 10.1016/j.ceb.2009.04.001, 19447594.
29. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001, 2(11):986-991. 10.1093/embo-reports/kve230, 1084129, 11713189.
30. Costa FF. Non-coding RNAs: new players in eukaryotic biology. Gene 2005, 357(2):83-94. 10.1016/j.gene.2005.06.019, 16111837.
31. Okamura K, Chung WJ, Ruby JG, Guo H, Bartel DP, Lai EC. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs. Nature 2008, 453(7196):803-806. 10.1038/nature07015, 2735555, 18463630.
32. Kawaji H, Hayashizaki Y. Exploration of small RNAs. PLoS Genet 2008, 4(1):e22. 10.1371/journal.pgen.0040022, 2213711, 18225959.
33. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233. 10.1016/j.cell.2009.01.002, 19167326.
34. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136(4):642-655. 10.1016/j.cell.2009.01.035, 2675692, 19239886.
35. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11(9):597-610.
36. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379. 10.1146/annurev-biochem-060308-103103, 20533884.
37. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009, 21(3):452-460. 10.1016/j.ceb.2009.04.009, 19450959.
38. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10(2):126-139. 10.1038/nrm2632, 19165215.
39. Taft RJ, Glazov EA, Cloonan N, Simons C, Stephen S, Faulkner GJ, Lassmann T, Forrest AR, Grimmond SM, Schroder K, et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet 2009, 41(5):572-578. 10.1038/ng.312, 19377478.
40. Taft RJ, Simons C, Nahkuri S, Oey H, Korbie DJ, Mercer TR, Holst J, Ritchie W, Wong JJ, Rasko JE, et al. Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat Struct Mol Biol 2010, 17(8):1030-1034. 10.1038/nsmb.1841, 20622877.
41. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011, 223(2):102-115. 10.1002/path.2806, 21125669.
42. Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet 2010, 70:87-99. full_text, 20920746.
43. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009, 27(34):5848-5856. 10.1200/JCO.2009.24.0317, 2793003, 19884536.
44. Chang LS, Lin SY, Lieu AS, Wu TL. Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun 2002, 299(2):196-200. 10.1016/S0006-291X(02)02623-2, 12437969.
45. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, Liu Z, Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 2010, 9:198. 10.1186/1476-4598-9-198, 2919450, 20663213.
46. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011, 331(6017):593-596. 10.1126/science.1200801, 21233348.
47. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J, Stern D, Tammana H, Helt G, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005, 308(5725):1149-1154. 10.1126/science.1108625, 15790807.
48. Wu Q, Kim YC, Lu J, Xuan Z, Chen J, Zheng Y, Zhou T, Zhang MQ, Wu CI, Wang SM. Poly A- transcripts expressed in HeLa cells. PLoS One 2008, 3(7):e2803. 10.1371/journal.pone.0002803, 2481391, 18665230.
49. Hawkins PG, Morris KV. Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcr 2010, 1(3):165-175.
50. Chen W, Bocker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol 1997, 183(3):345-351. 10.1002/(SICI)1096-9896(199711)183:3<345::AID-PATH930>3.0.CO;2-8, 9422992.
51. Iacoangeli A, Lin Y, Morley EJ, Muslimov IA, Bianchi R, Reilly J, Weedon J, Diallo R, Bocker W, Tiedge H. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 2004, 25(11):2125-2133. 10.1093/carcin/bgh228, 15240511.
52. Ramskold D, Wang ET, Burge CB, Sandberg R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol 2009, 5(12):e1000598. 10.1371/journal.pcbi.1000598, 2781110, 20011106.
53. Guttman M, Garber M, Levin JZ, Donaghey J, Robinson J, Adiconis X, Fan L, Koziol MJ, Gnirke A, Nusbaum C, et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol 2010, 28(5):503-510. 10.1038/nbt.1633, 2868100, 20436462.
54. Babak T, Blencowe BJ, Hughes TR. A systematic search for new mammalian noncoding RNAs indicates little conserved intergenic transcription. BMC Genomics 2005, 6:104. 10.1186/1471-2164-6-104, 1199595, 16083503.
55. Bono H, Yagi K, Kasukawa T, Nikaido I, Tominaga N, Miki R, Mizuno Y, Tomaru Y, Goto H, Nitanda H, et al. Systematic expression profiling of the mouse transcriptome using RIKEN cDNA microarrays. Genome Res 2003, 13(6B):1318-1323. 10.1101/gr.1075103, 403653, 12819129.
56. Yang L, Duff MO, Graveley BR, Carmichael GG, Chen LL. Genomewide characterization of non-polyadenylated RNAs. Genome Biol 2011, 12(2):R16. 10.1186/gb-2011-12-2-r16, 21324177.
57. Kapranov P, St Laurent G, Raz T, Ozsolak F, Reynolds CP, Sorensen PH, Reaman G, Milos P, Arceci RJ, Thompson JF, et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol 2010, 8:149. 10.1186/1741-7007-8-149, 3022773, 21176148.
58. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009, 106(28):11667-11672. 10.1073/pnas.0904715106, 2704857, 19571010.
59. Mestdagh P, Fredlund E, Pattyn F, Rihani A, Van Maerken T, Vermeulen J, Kumps C, Menten B, De Preter K, Schramm A, et al. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours. Oncogene 2010, 29(24):3583-3592. 10.1038/onc.2010.106, 20383195.
60. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143(1):46-58. 10.1016/j.cell.2010.09.001, 20887892.
61. Chen LL, Carmichael GG. Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol 2010, 22(3):357-364. 10.1016/j.ceb.2010.03.003, 20356723.
62. Lipovich L, Johnson R, Lin CY. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 2010, 1799(9):597-615.
63. Costa FF. Non-coding RNAs, epigenetics and complexity. Gene 2008, 410(1):9-17. 10.1016/j.gene.2007.12.008, 18226475.
64. Yang PK, Kuroda MI. Noncoding RNAs and intranuclear positioning in monoallelic gene expression. Cell 2007, 128(4):777-786. 10.1016/j.cell.2007.01.032, 17320513.
65. Heard E, Disteche CM. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev 2006, 20(14):1848-1867. 10.1101/gad.1422906, 16847345.
66. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010, 39(6):925-938. 10.1016/j.molcel.2010.08.011, 20797886.
67. Goodrich JA, Kugel JF. Non-coding-RNA regulators of RNA polymerase II transcription. Nat Rev Mol Cell Biol 2006, 7(8):612-616. 10.1038/nrm1946, 16723972.
68. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076. 10.1038/nature08975, 3049919, 20393566.
69. Prasanth KV, Spector DL. Eukaryotic regulatory RNAs: an answer to the 'genome complexity' conundrum. Genes Dev 2007, 21(1):11-42. 10.1101/gad.1484207, 17210785.
70. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011, 470(7333):284-288. 10.1038/nature09701, 21307942.
71. Huarte M, Rinn JL. Large non-coding RNAs: missing links in cancer?. Hum Mol Genet 2010, 19(R2):R152-161. 10.1093/hmg/ddq353, 20729297.
72. Kondo T, Plaza S, Zanet J, Benrabah E, Valenti P, Hashimoto Y, Kobayashi S, Payre F, Kageyama Y. Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis. Science 2010, 329(5989):336-339. 10.1126/science.1188158, 20647469.
73. Ulveling D, Francastel C, Hube F. When one is better than two: RNA with dual functions. Biochimie 2010,
74. Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol 1990, 10(1):28-36. 360709, 1688465.
75. Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, Willard HF. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 1991, 349(6304):38-44. 10.1038/349038a0, 1985261.
76. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854. 10.1016/0092-8674(93)90529-Y, 8252621.
77. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294(5543):858-862. 10.1126/science.1065062, 11679671.
78. Reinhart BJ, Weinstein EG, Rhoades MW, Bartel B, Bartel DP. MicroRNAs in plants. Genes Dev 2002, 16(13):1616-1626. 10.1101/gad.1004402, 186362, 12101121.
79. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99(24):15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
80. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36 Database issue:D154-158.
81. Griffiths-Jones S. miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics 2010, Chapter 12:Unit 12 19 11-10.
82. Berezikov E, Plasterk RH. Camels and zebrafish, viruses and cancer: a microRNA update. Hum Mol Genet 2005, 14(2):R183-190. 10.1093/hmg/ddi271, 16244316.
83. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1):92-105. 10.1101/gr.082701.108, 2612969, 18955434.
84. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, et al. Functional annotation of a full-length mouse cDNA collection. Nature 2001, 409(6821):685-690. 10.1038/35055500, 11217851.
85. Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa A, Bonassi S, Tonini GP. Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer 2009, 9:441. 10.1186/1471-2407-9-441, 2804711, 20003513.
86. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993, 362(6422):747-749. 10.1038/362747a0, 8385745.
87. Wood AJ, Oakey RJ. Genomic imprinting in mammals: emerging themes and established theories. PLoS Genet 2006, 2(11):e147. 10.1371/journal.pgen.0020147, 1657038, 17121465.
88. Feil R, Berger F. Convergent evolution of genomic imprinting in plants and mammals. Trends Genet 2007, 23(4):192-199. 10.1016/j.tig.2007.02.004, 17316885.
89. Wan LB, Bartolomei MS. Regulation of imprinting in clusters: noncoding RNAs versus insulators. Adv Genet 2008, 61:207-223. full_text, 18282507.
90. Lim DH, Maher ER. Genomic imprinting syndromes and cancer. Adv Genet 2010, 70:145-175. full_text, 20920748.
91. Monk D. Deciphering the cancer imprintome. Brief Funct Genomics 2010, 9(4):329-339.
92. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010, 32(6):473-480. 10.1002/bies.200900170, 20486133.
93. Poirier F, Chan CT, Timmons PM, Robertson EJ, Evans MJ, Rigby PW. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991, 113(4):1105-1114.
94. Lustig O, Ariel I, Ilan J, Lev-Lehman E, De-Groot N, Hochberg A. Expression of the imprinted gene H19 in the human fetus. Mol Reprod Dev 1994, 38(3):239-246. 10.1002/mrd.1080380302, 7917273.
95. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H. Loss of H19 imprinting in esophageal cancer. Cancer Res 1996, 56(3):480-482.
96. Fellig Y, Ariel I, Ohana P, Schachter P, Sinelnikov I, Birman T, Ayesh S, Schneider T, de Groot N, Czerniak A, et al. H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol 2005, 58(10):1064-1068. 10.1136/jcp.2004.023648, 1770739, 16189152.
97. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2(9):e845. 10.1371/journal.pone.0000845, 1959184, 17786216.
98. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006, 66(10):5330-5337. 10.1158/0008-5472.CAN-06-0037, 16707459.
99. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T, Adriaenssens E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem 2005, 280(33):29625-29636. 10.1074/jbc.M504033200, 15985428.
100. Dugimont T, Montpellier C, Adriaenssens E, Lottin S, Dumont L, Iotsova V, Lagrou C, Stehelin D, Coll J, Curgy JJ. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene 1998, 16(18):2395-2401. 10.1038/sj.onc.1201742, 9620557.
101. Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 2010, 396(1):85-89. 10.1016/j.bbrc.2010.02.152, 20494116.
102. Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA 2007, 13(3):313-316. 10.1261/rna.351707, 1800509, 17237358.
103. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010, 31(3):350-358. 10.1093/carcin/bgp181, 19926638.
104. Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, Colnot S, Godard C, Terris B, Jammes H, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008, 105(34):12417-12422. 10.1073/pnas.0801540105, 2527926, 18719115.
105. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993, 365(6448):764-767. 10.1038/365764a0, 7692308.
106. Colnot S, Niwa-Kawakita M, Hamard G, Godard C, Le Plenier S, Houbron C, Romagnolo B, Berrebi D, Giovannini M, Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest 2004, 84(12):1619-1630. 10.1038/labinvest.3700180, 15502862.
107. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 1995, 9(17):2079-2089. 10.1101/gad.9.17.2079, 7544754.
108. Kanduri C, Whitehead J, Mohammad F. The long and the short of it: RNA-directed chromatin asymmetry in mammalian X-chromosome inactivation. FEBS Lett 2009, 583(5):857-864. 10.1016/j.febslet.2009.02.004, 19302783.
109. Leeb M, Steffen PA, Wutz A. X chromosome inactivation sparked by non-coding RNAs. RNA Biol 2009, 6(2):94-99. 10.4161/rna.6.2.7716, 19246991.
110. Payer B, Lee JT. X chromosome dosage compensation: how mammals keep the balance. Annu Rev Genet 2008, 42:733-772. 10.1146/annurev.genet.42.110807.091711, 18729722.
111. Kay GF, Barton SC, Surani MA, Rastan S. Imprinting and X chromosome counting mechanisms determine Xist expression in early mouse development. Cell 1994, 77(5):639-650. 10.1016/0092-8674(94)90049-3, 8205614.
112. Lee JT, Davidow LS, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 1999, 21(4):400-404. 10.1038/7734, 10192391.
113. Tian D, Sun S, Lee JT. The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell 2010, 143(3):390-403. 10.1016/j.cell.2010.09.049, 21029862.
114. Chureau C, Chantalat S, Romito A, Galvani A, Duret L, Avner P, Rougeulle C. Ftx is a non-coding RNA which affects Xist expression and chromatin structure within the X-inactivation center region. Hum Mol Genet 2010,
115. Ogawa Y, Lee JT. Xite, X-inactivation intergenic transcription elements that regulate the probability of choice. Mol Cell 2003, 11(3):731-743. 10.1016/S1097-2765(03)00063-7, 12667455.
116. Ogawa Y, Sun BK, Lee JT. Intersection of the RNA interference and X-inactivation pathways. Science 2008, 320(5881):1336-1341. 10.1126/science.1157676, 2584363, 18535243.
117. Migeon BR. Is Tsix repression of Xist specific to mouse?. Nat Genet 2003, 33(3):337; author reply 337-338.
118. Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 2002, 1(10):769-776.
119. Wutz A, Jaenisch R. A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell 2000, 5(4):695-705. 10.1016/S1097-2765(00)80248-8, 10882105.
120. Brown CJ, Willard HF. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 1994, 368(6467):154-156. 10.1038/368154a0, 8139659.
121. Vincent-Salomon A, Ganem-Elbaz C, Manie E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH, Heard E. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 2007, 67(11):5134-5140. 10.1158/0008-5472.CAN-07-0465, 17545591.
122. Sirchia SM, Tabano S, Monti L, Recalcati MP, Gariboldi M, Grati FR, Porta G, Finelli P, Radice P, Miozzo M. Misbehaviour of XIST RNA in breast cancer cells. PLoS One 2009, 4(5):e5559. 10.1371/journal.pone.0005559, 2679222, 19440381.
123. Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, et al. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 2005, 65(6):2139-2146. 10.1158/0008-5472.CAN-04-3465, 15781624.
124. Pageau GJ, Hall LL, Ganesan S, Livingston DM, Lawrence JB. The disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer 2007, 7(8):628-633. 10.1038/nrc2172, 17611545.
125. Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sherman SP, Aimiuwu O, Lindgren A, Hakimian S, Zack JA, et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010, 7(3):329-342. 10.1016/j.stem.2010.06.024, 20727844.
126. Silva SS, Rowntree RK, Mekhoubad S, Lee JT. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci USA 2008, 105(12):4820-4825. 10.1073/pnas.0712136105, 2290799, 18339803.
127. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434(7031):400-404. 10.1038/nature03479, 15772666.
128. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329(5992):689-693. 10.1126/science.1192002, 2967777, 20616235.
129. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 2009, 10(10):697-708.
130. Morey L, Helin K. Polycomb group protein-mediated repression of transcription. Trends Biochem Sci 2010, 35(6):323-332. 10.1016/j.tibs.2010.02.009, 20346678.
131. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, Lee JT. Genome-wide Identification of Polycomb-Associated RNAs by RIP-seq. Mol Cell 2010, 40(6):939-953. 10.1016/j.molcel.2010.12.011, 21172659.
132. Zhang Z, Jones A, Sun CW, Li C, Chang CW, Joo HY, Dai Q, Mysliwiec MR, Wu LC, Guo Y, et al. PRC2 Complexes with JARID2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprogramming. Stem Cells 2010,
133. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008, 647(1-2):21-29.
134. Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsunoda T, Field HI, Neal DE, Yamaue H, Ponder BA, et al. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 2011, 128(3):574-586. 10.1002/ijc.25349, 20333681.
135. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(39):8031-8041. 10.1038/sj.onc.1206928, 12970751.
136. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 2007, 8:39. 10.1186/1471-2164-8-39, 1800850, 17270048.
137. Yamada K, Kano J, Tsunoda H, Yoshikawa H, Okubo C, Ishiyama T, Noguchi M. Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci 2006, 97(2):106-112. 10.1111/j.1349-7006.2006.00147.x, 16441420.
138. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26(6):851-858. 10.1038/sj.onc.1209846, 16878148.
139. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006, 44(4):1012-1024. 10.1002/hep.21328, 1769554, 17006932.
140. Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi M, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 2003, 100(10):6051-6056. 10.1073/pnas.0931430100, 156324, 12719541.
141. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E, Bridge J, Schuuring E, Schoenmakers EF, van Kessel AG. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 2003, 12(14):1661-1669. 10.1093/hmg/ddg178, 12837690.
142. Rajaram V, Knezevich S, Bove KE, Perry A, Pfeifer JD. DNA sequence of the translocation breakpoints in undifferentiated embryonal sarcoma arising in mesenchymal hamartoma of the liver harboring the t(11;19)(q11;q13.4) translocation. Genes Chromosomes Cancer 2007, 46(5):508-513. 10.1002/gcc.20437, 17311249.
143. Wilusz JE, Freier SM, Spector DL. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008, 135(5):919-932. 10.1016/j.cell.2008.10.012, 2722846, 19041754.
144. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316(5830):1484-1488. 10.1126/science.1138341, 17510325.
145. Mercer TR, Wilhelm D, Dinger ME, Solda G, Korbie DJ, Glazov EA, Truong V, Schwenke M, Simons C, Matthaei KI, et al. Expression of distinct RNAs from 3' untranslated regions. Nucleic Acids Res 2010, 3064787, 21075793.
146. Mercer TR, Dinger ME, Bracken CP, Kolle G, Szubert JM, Korbie DJ, Askarian-Amiri ME, Gardiner BB, Goodall GJ, Grimmond SM, et al. Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome. Genome Res 2010, 20(12):1639-1650. 10.1101/gr.112128.110, 21045082.
147. Ni T, Corcoran DL, Rach EA, Song S, Spana EP, Gao Y, Ohler U, Zhu J. A paired-end sequencing strategy to map the complex landscape of transcription initiation. Nat Methods 2010, 7(7):521-527. 10.1038/nmeth.1464, 20495556.
148. Otsuka Y, Kedersha NL, Schoenberg DR. Identification of a cytoplasmic complex that adds a cap onto 5'-monophosphate RNA. Mol Cell Biol 2009, 29(8):2155-2167. 10.1128/MCB.01325-08, 2663312, 19223470.
149. Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature 2009, 457(7232):1028-1032. 10.1038/nature07759, 2719882, 19169241.
150. Bernard D, Prasanth KV, Tripathi V, Colasse S, Nakamura T, Xuan Z, Zhang MQ, Sedel F, Jourdren L, Coulpier F, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 2010, 29(18):3082-3093. 10.1038/emboj.2010.199, 20729808.
151. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 2010, 584(22):4575-4580. 10.1016/j.febslet.2010.10.008, 20937273.
152. Guo F, Li Y, Liu Y, Wang J, Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 2010, 42(3):224-229. 10.1093/abbs/gmq008, 20213048.
153. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005, 102(10):3627-3632. 10.1073/pnas.0500613102, 552785, 15738415.
154. Mestdagh P, Bostrom AK, Impens F, Fredlund E, Van Peer G, De Antonellis P, von Stedingk K, Ghesquiere B, Schulte S, Dews M, et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol Cell 2010, 40(5):762-773. 10.1016/j.molcel.2010.11.038, 21145484.
155. Zhao R, Bodnar MS, Spector DL. Nuclear neighborhoods and gene expression. Curr Opin Genet Dev 2009, 19(2):172-179. 10.1016/j.gde.2009.02.007, 2677118, 19339170.
156. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino T, Ishino F. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 2000, 5(3):211-220. 10.1046/j.1365-2443.2000.00320.x, 10759892.
157. Zhang X, Zhou Y, Mehta KR, Danila DC, Scolavino S, Johnson SR, Klibanski A. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab 2003, 88(11):5119-5126. 10.1210/jc.2003-030222, 14602737.
158. Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, Zhou Y, Klibanski A. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 2010, 151(3):939-947. 10.1210/en.2009-0657, 2840681, 20032057.
159. Hagan JP, O'Neill BL, Stewart CL, Kozlov SV, Croce CM. At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One 2009, 4(2):e4352. 10.1371/journal.pone.0004352, 2632752, 19194500.
160. Schuster-Gossler K, Bilinski P, Sado T, Ferguson-Smith A, Gossler A. The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn 1998, 212(2):214-228. 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K, 9626496.
161. Mondal T, Rasmussen M, Pandey GK, Isaksson A, Kanduri C. Characterization of the RNA content of chromatin. Genome Res 2010, 20(7):899-907. 10.1101/gr.103473.109, 2892091, 20404130.
162. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007, 282(34):24731-24742. 10.1074/jbc.M702029200, 17569660.
163. Pang KC, Frith MC, Mattick JS. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet 2006, 22(1):1-5. 10.1016/j.tig.2005.10.003, 16290135.
164. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010, 142(3):409-419. 10.1016/j.cell.2010.06.040, 20673990.
165. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006, 103(24):9136-9141. 10.1073/pnas.0508889103, 1474008, 16754881.
166. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004, 101(9):2999-3004. 10.1073/pnas.0307323101, 365734, 14973191.
167. Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007, 6(9):1001-1005. 10.4161/cc.6.9.4209, 17457051.
168. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008, 214(1):17-24. 10.1002/path.2251, 17948228.
169. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007, 4(9):721-726. 10.1038/nmeth1079, 17694064.
170. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132(1):330-342. 10.1053/j.gastro.2006.08.026, 17241883.
171. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H, Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009, 21(6):688-692. 10.1097/MEG.0b013e328306a3a2, 19445043.
172. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010, 38(16):5366-5383. 10.1093/nar/gkq285, 2938198, 20423907.
173. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465(7301):1033-1038. 10.1038/nature09144, 20577206.
174. Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, Egia A, Salmena L, Sampieri K, Haveman WJ, Brogi E, et al. Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 2010, 42(5):454-458. 10.1038/ng.556, 20400965.
175. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, Cui H. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 2008, 451(7175):202-206. 10.1038/nature06468, 2743558, 18185590.
176. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, Paulsson-Berne G, Hamsten A, Hugh W, Franco-Cereceda A, Gabrielsen A, et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009, 4(11):e7677. 10.1371/journal.pone.0007677, 2765615, 19888323.
177. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366(6456):704-707. 10.1038/366704a0, 8259215.
178. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264(5157):436-440. 10.1126/science.8153634, 8153634.
179. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91(5):649-659. 10.1016/S0092-8674(00)80452-3, 9393858.
180. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397(6715):164-168. 10.1038/16476, 9923679.
181. Popov N, Gil J. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 2010, 5(8):685-690. 10.4161/epi.5.8.12996, 20716961.
182. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 2010, 6(4):e1000899. 10.1371/journal.pgen.1000899, 2851566, 20386740.
183. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010, 38(5):662-674. 10.1016/j.molcel.2010.03.021, 20541999.
184. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2010,
185. Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG. Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 2008, 4(11):e1000258. 10.1371/journal.pgen.1000258, 2576438, 19008947.
186. Szell M, Bata-Csorgo Z, Kemeny L. The enigmatic world of mRNA-like ncRNAs: their role in human evolution and in human diseases. Semin Cancer Biol 2008, 18(2):141-148. 10.1016/j.semcancer.2008.01.007, 18282717.
187. Chung S, Nakagawa H, Uemura M, Piao L, Ashikawa K, Hosono N, Takata R, Akamatsu S, Kawaguchi T, Morizono T, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011, 102(1):245-252. 10.1111/j.1349-7006.2010.01737.x, 20874843.
188. Petrovics G, Zhang W, Makarem M, Street JP, Connelly R, Sun L, Sesterhenn IA, Srikantan V, Moul JW, Srivastava S. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 2004, 23(2):605-611. 10.1038/sj.onc.1207069, 14724589.
189. Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999, 59(23):5975-5979.
190. de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002, 62(9):2695-2698.
191. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. Trends Genet 2007, 23(12):614-622. 10.1016/j.tig.2007.09.001, 17977614.
192. White RJ. RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 2008, 24(12):622-629. 10.1016/j.tig.2008.10.003, 18980784.
193. White RJ. RNA polymerase III transcription and cancer. Oncogene 2004, 23(18):3208-3216. 10.1038/sj.onc.1207547, 15094770.
194. Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, et al. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. PLoS Med 2010, 7(7):e1000315. 10.1371/journal.pmed.1000315, 2910599, 20668658.
195. Marshall L, White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008, 8(12):911-914. 10.1038/nrc2539, 18987635.
196. Watson JB, Sutcliffe JG. Primate brain-specific cytoplasmic transcript of the Alu repeat family. Mol Cell Biol 1987, 7(9):3324-3327. 367971, 2444875.
197. Tiedge H, Chen W, Brosius J. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J Neurosci 1993, 13(6):2382-2390.
198. Martignetti JA, Brosius J. BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proc Natl Acad Sci USA 1993, 90(24):11563-11567. 10.1073/pnas.90.24.11563, 48024, 8265590.
199. Lin D, Pestova TV, Hellen CU, Tiedge H. Translational control by a small RNA: dendritic BC1 RNA targets the eukaryotic initiation factor 4A helicase mechanism. Mol Cell Biol 2008, 28(9):3008-3019. 10.1128/MCB.01800-07, 2293081, 18316401.
200. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007, 12(3):215-229. 10.1016/j.ccr.2007.07.027, 17785203.
201. Katzman S, Kern AD, Bejerano G, Fewell G, Fulton L, Wilson RK, Salama SR, Haussler D. Human genome ultraconserved elements are ultraselected. Science 2007, 317(5840):915. 10.1126/science.1142430, 17702936.
202. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D. Ultraconserved elements in the human genome. Science 2004, 304(5675):1321-1325. 10.1126/science.1098119, 15131266.
203. Braconi C, Valeri N, Kogure T, Gasparini P, Huang N, Nuovo GJ, Terracciano L, Croce CM, Patel T. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA 2010,
204. Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller M. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 2010, 29(48):6390-6401. 10.1038/onc.2010.361, 3007676, 20802525.
205. Morris KV. RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides 2009, 19(4):299-306. 10.1089/oli.2009.0212, 2861411,2861411, 19943804.
206. Scholer N, Langer C, Dohner H, Buske C, Kuchenbauer F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp Hematol 2010, 38(12):1126-1130. 10.1016/j.exphem.2010.10.004, 20977925.
207. Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010, 67(2):170-176. 10.1016/j.lungcan.2009.04.004, 2846426, 19446359.
208. Xing L, Todd NW, Yu L, Fang H, Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010, 23(8):1157-1164. 10.1038/modpathol.2010.111, 20526284.
209. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010, 101(10):2087-2092. 10.1111/j.1349-7006.2010.01650.x, 20624164.
210. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, Jocham D, Warnecke JM, Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010, 28(6):655-661.
211. Tinzl M, Marberger M, Horvath S, Chypre C. DD3PCA3 RNA analysis in urine--a new perspective for detecting prostate cancer. Eur Urol 2004, 46(2):182-186. discussion 187, 10.1016/j.eururo.2004.06.004, 15245811.
212. Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003, 44(1):8-15. discussion 15-16, 10.1016/S0302-2838(03)00201-X, 12814669.
213. Costa FF. Non-coding RNAs and new opportunities for the private sector. Drug Discov Today 2009, 14(9-10):446-452. 10.1016/j.drudis.2009.01.008, 19429503.
214. Hung T, Chang HY. Long noncoding RNA in genome regulation: Prospects and mechanisms. RNA Biol 2010, 7(5). 10.4161/rna.7.5.13216, 20930520.
215. Tsai MC, Spitale RC, Chang HY. Long Intergenic Noncoding RNAs: New Links in Cancer Progression. Cancer Res 2011, 71(1):3-7. 10.1158/0008-5472.CAN-10-2483, 21199792.
216. Smaldone MC, Davies BJ. BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther 2010, 12(5):607-616.
217. Midoux P, Breuzard G, Gomez JP, Pichon C. Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Curr Gene Ther 2008, 8(5):335-352. 10.2174/156652308786071014, 18855631.
218. Amit D, Hochberg A. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med 2010, 8(1):134. 10.1186/1479-5876-8-134, 3016259, 21162716.
219. Ohana P, Gofrit O, Ayesh S, Al-Sharef W, Mizrahi A, Birman T, Schneider T, Matouk I, de Groot N, Tavdy E, et al. Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer. Gene Therapy and Molecular Biology 2004, 8:181-192.
220. Scaiewicz V, Sorin V, Fellig Y, Birman T, Mizrahi A, Galula J, Abu-Lail R, Shneider T, Ohana P, Buscail L, et al. Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer. J Oncol 2010, 2010:178174. 2967839, 21052499.
221. Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I, Abu-lail R, Sorin V, Birman T, de Groot N, et al. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med 2009, 7:69. 10.1186/1479-5876-7-69, 2734756, 19656414.
222. Phizicky EM, Hopper AK. tRNA biology charges to the front. Genes Dev 2010, 24(17):1832-1860. 10.1101/gad.1956510, 2932967, 20810645.
223. Hannan KM, Hannan RD, Rothblum LI. Transcription by RNA polymerase I. Front Biosci 1998, 3:d376-398.
224. Stults DM, Killen MW, Pierce HH, Pierce AJ. Genomic architecture and inheritance of human ribosomal RNA gene clusters. Genome Res 2008, 18(1):13-18. 10.1101/gr.6858507, 2134781, 18025267.
225. Lin H. piRNAs in the germ line. Science 2007, 316(5823):397. 10.1126/science.1137543, 17446387.
226. Kapranov P, Ozsolak F, Kim SW, Foissac S, Lipson D, Hart C, Roels S, Borel C, Antonarakis SE, Monaghan AP, et al. New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism. Nature 2010, 466(7306):642-646. 10.1038/nature09190, 3058539, 20671709.
227. Kiss T. Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J 2001, 20(14):3617-3622. 10.1093/emboj/20.14.3617, 125535, 11447102.
228. Filipowicz W, Pogacic V. Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol 2002, 14(3):319-327. 10.1016/S0955-0674(02)00334-4, 12067654.
229. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA. Divergent transcription from active promoters. Science 2008, 322(5909):1849-1851. 10.1126/science.1162253, 2692996, 19056940.
230. Valadkhan S. snRNAs as the catalysts of pre-mRNA splicing. Curr Opin Chem Biol 2005, 9(6):603-608. 10.1016/j.cbpa.2005.10.008, 16242989.
231. Faulkner GJ, Carninci P. Altruistic functions for selfish DNA. Cell Cycle 2009, 8(18):2895-2900. 10.4161/cc.8.18.9536, 19736519.
232. Faulkner GJ, Kimura Y, Daub CO, Wani S, Plessy C, Irvine KM, Schroder K, Cloonan N, Steptoe AL, Lassmann T, et al. The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 2009, 41(5):563-571. 10.1038/ng.368, 19377475.
233. Kandhavelu M, Lammi C, Buccioni M, Dal Ben D, Volpini R, Marucci G. Existence of snoRNA, microRNA, piRNA characteristics in a novel non-coding RNA: x-ncRNA and its biological implication in Homo sapiens. Journal of Bioinformatics and Sequence Analysis 2009, 1(2):31-40.
234. Christov CP, Gardiner TJ, Szuts D, Krude T. Functional requirement of noncoding Y RNAs for human chromosomal DNA replication. Mol Cell Biol 2006, 26(18):6993-7004. 10.1128/MCB.01060-06, 1592862, 16943439.
235. Li Z, Kim SW, Lin Y, Moore PS, Chang Y, John B. Characterization of viral and human RNAs smaller than canonical MicroRNAs. J Virol 2009, 83(24):12751-12758. 10.1128/JVI.01325-09, 2786840, 19812168.
236. Parrott AM, Mathews MB. snaR genes: recent descendants of Alu involved in the evolution of chorionic gonadotropins. Cold Spring Harb Symp Quant Biol 2009, 74:363-373. 10.1101/sqb.2009.74.038, 20028844.
237. Parrott AM, Tsai M, Batchu P, Ryan K, Ozer HL, Tian B, Mathews MB. The evolution and expression of the snaR family of small non-coding RNAs. Nucleic Acids Res 2011, 39(4):1485-1500. 10.1093/nar/gkq856, 3045588, 20935053.
238. Stadler PF, Chen JJ, Hackermuller J, Hoffmann S, Horn F, Khaitovich P, Kretzschmar AK, Mosig A, Prohaska SJ, Qi X, et al. Evolution of vault RNAs. Mol Biol Evol 2009, 26(9):1975-1991. 10.1093/molbev/msp112, 19491402.
239. Zheng D, Frankish A, Baertsch R, Kapranov P, Reymond A, Choo SW, Lu Y, Denoeud F, Antonarakis SE, Snyder M, et al. Pseudogenes in the ENCODE regions: consensus annotation, analysis of transcription, and evolution. Genome Res 2007, 17(6):839-851. 10.1101/gr.5586307, 1891343, 17568002.
240. Zhang ZD, Frankish A, Hunt T, Harrow J, Gerstein M. Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates. Genome Biol 2010, 11(3):R26. 10.1186/gb-2010-11-3-r26, 2864566, 20210993.
241. Zheng R, Shen Z, Tripathi V, Xuan Z, Freier SM, Bennett CF, Prasanth SG, Prasanth KV. Polypurine-repeat-containing RNAs: a novel class of long non-coding RNA in mammalian cells. J Cell Sci 2010, 123(Pt 21):3734-3744. 10.1242/jcs.070466, 20940252.
242. Louro R, Smirnova AS, Verjovski-Almeida S. Long intronic noncoding RNA transcription: expression noise or expression choice?. Genomics 2009, 93(4):291-298. 10.1016/j.ygeno.2008.11.009, 19071207.
243. Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res 2010, 3064772, 21071396.
244. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, et al. Antisense transcription in the mammalian transcriptome. Science 2005, 309(5740):1564-1566. 10.1126/science.1112009, 16141073.
245. Preker P, Nielsen J, Kammler S, Lykke-Andersen S, Christensen MS, Mapendano CK, Schierup MH, Jensen TH. RNA exosome depletion reveals transcription upstream of active human promoters. Science 2008, 322(5909):1851-1854. 10.1126/science.1164096, 19056938.
246. Zhang Y, Guan DG, Yang JH, Shao P, Zhou H, Qu LH. ncRNAimprint: a comprehensive database of mammalian imprinted noncoding RNAs. RNA 2010, 16(10):1889-1901. 10.1261/rna.2226910, 2941098, 20801769.
247. Szymanski M, Erdmann VA, Barciszewski J. Noncoding RNAs database (ncRNAdb). Nucleic Acids Res 2007, 35(Database issue):D162-164. 10.1093/nar/gkl994, 1781251, 17169980.
248. Mituyama T, Yamada K, Hattori E, Okida H, Ono Y, Terai G, Yoshizawa A, Komori T, Asai K. The Functional RNA Database 3.0: databases to support mining and annotation of functional RNAs. Nucleic Acids Res 2009, 37(Database issue):D89-92. 10.1093/nar/gkn805, 2686472, 18948287.
249. Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y, Bu D, Zhao Y, Chen R. NONCODE: an integrated knowledge database of non-coding RNAs. Nucleic Acids Res 2005, 33(Database issue):D112-115. 10.1093/nar/gki041, 539995, 15608158.
250. Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS. lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 2011, 39(Database issue):D146-151. 10.1093/nar/gkq1138, 3013714, 21112873.
251. Gardner PP, Daub J, Tate JG, Nawrocki EP, Kolbe DL, Lindgreen S, Wilkinson AC, Finn RD, Griffiths-Jones S, Eddy SR, et al. Rfam: updates to the RNA families database. Nucleic Acids Res 2009, 37(Database issue):D136-140. 10.1093/nar/gkn766, 2686503, 18953034.
252. Dinger ME, Pang KC, Mercer TR, Crowe ML, Grimmond SM, Mattick JS. NRED: a database of long noncoding RNA expression. Nucleic Acids Res 2009, 37(Database issue):D122-126. 10.1093/nar/gkn617, 2686506, 18829717.
253. Erdmann VA, Szymanski M, Hochberg A, Groot N, Barciszewski J. Non-coding, mRNA-like RNAs database Y2K. Nucleic Acids Res 2000, 28(1):197-200. 10.1093/nar/28.1.197, 102406, 10592224.
254. Wu T, Wang J, Liu C, Zhang Y, Shi B, Zhu X, Zhang Z, Skogerbo G, Chen L, Lu H, et al. NPInter: the noncoding RNAs and protein related biomacromolecules interaction database. Nucleic Acids Res 2006, 34(Database issue):D150-152. 10.1093/nar/gkj025, 1347388, 16381834.
255. Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A. Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol 2007, 20(10):1085-1094. 10.1038/modpathol.3800937, 17660802.
256. Koshimizu TA, Fujiwara Y, Sakai N, Shibata K, Tsuchiya H. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci 2010, 86(11-12):455-460. 10.1016/j.lfs.2010.02.001, 20149803.
257. Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, et al. The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol 2000, 53(6):320-323. 10.1136/mp.53.6.320, 1186987, 11193051.
258. Yballe CM, Vu TH, Hoffman AR. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. J Clin Endocrinol Metab 1996, 81(4):1607-1612. 10.1210/jc.81.4.1607, 8636375.
259. Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer 2004, 14(3):521-525. 10.1111/j.1048-891x.2004.014314.x, 15228427.
260. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 1996, 12(2):423-430.
261. Arima T, Matsuda T, Takagi N, Wake N. Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet 1997, 93(1):39-47. 10.1016/S0165-4608(96)00221-X, 9062579.
262. Tanos V, Prus D, Ayesh S, Weinstein D, Tykocinski ML, De-Groot N, Hochberg A, Ariel I. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999, 85(1):7-11. 10.1016/S0301-2115(98)00275-9, 10428315.
263. Berteaux N, Lottin S, Adriaenssens E, Van Coppenolle F, Leroy X, Coll J, Dugimont T, Curgy JJ. Hormonal regulation of H19 gene expression in prostate epithelial cells. J Endocrinol 2004, 183(1):69-78. 10.1677/joe.1.05696, 15525575.
264. Kondo M, Takahashi T. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer]. Nippon Rinsho 1996, 54(2):492-496.
265. Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, Novokmet A, Malkin D. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res 2010, 70(1):160-171. 10.1158/0008-5472.CAN-09-1902, 20048075.
266. Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA 2000, 97(22):12216-12221. 10.1073/pnas.97.22.12216, 17321, 11050243.
267. Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 2006, 25(3):135-141. 10.1089/dna.2006.25.135, 16569192.
268. Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 2006, 12(16):4851-4858. 10.1158/1078-0432.CCR-06-0134, 16914571.
269. Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008, 582(13):1919-1927. 10.1016/j.febslet.2008.05.012, 18501714.
270. Tsang WP, Wong TW, Cheung AH, Co CN, Kwok TT. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA 2007, 13(6):890-898. 10.1261/rna.359007, 1869035, 17416635.
271. Korneev SA, Korneeva EI, Lagarkova MA, Kiselev SL, Critchley G, O'Shea M. Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells. RNA 2008, 14(10):2030-2037. 10.1261/rna.1084308, 2553742, 18820242.
272. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007, 67(8):3963-3969. 10.1158/0008-5472.CAN-06-2004, 17440112.
273. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009, 28(2):195-208. 10.1038/onc.2008.373, 18836484.
274. Leygue E. Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer. Nucl Recept Signal 2007, 5:e006. 1948073, 17710122.
275. Chooniedass-Kothari S, Hamedani MK, Troup S, Hube F, Leygue E. The steroid receptor RNA activator protein is expressed in breast tumor tissues. Int J Cancer 2006, 118(4):1054-1059. 10.1002/ijc.21425, 16152589.
276. Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J, Gao Z. ncRAN, a Newly Identified Long Noncoding RNA, Enhances Human Bladder Tumor Growth, Invasion, and Survival. Urology 2010, 77(2):510 e511-515.
277. Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol 2009, 34(4):931-938.